CHST14 Gene Ehlers-Danlos Syndrome Musculocontractural Type 1 NGS Genetic DNA Test
Introduction to the Test
The CHST14 Gene Ehlers-Danlos Syndrome Musculocontractural Type 1 NGS Genetic DNA Test is a specialized diagnostic tool designed to identify mutations in the CHST14 gene, which is responsible for certain types of connective tissue disorders. This test is essential for patients who exhibit symptoms of Ehlers-Danlos syndrome (EDS), particularly the musculocontractural type 1, which can lead to serious health implications if left undiagnosed.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to detect specific alterations in the CHST14 gene. It provides a comprehensive analysis of the gene’s structure and function, allowing healthcare providers to confirm or rule out a diagnosis of EDS.
Who Should Consider This Test?
- Individuals with a family history of Ehlers-Danlos syndrome.
- Patients presenting symptoms such as hypermobility, joint pain, or skin elasticity issues.
- Those experiencing complications related to connective tissue disorders.
Benefits of Taking the Test
- Early diagnosis can lead to better management of symptoms and prevention of complications.
- Understanding genetic risks can inform family planning and lifestyle choices.
- Access to tailored treatment options based on genetic findings.
Understanding Your Results
Results from the CHST14 Gene Ehlers-Danlos Syndrome Musculocontractural Type 1 NGS Genetic DNA Test typically take 3 to 4 weeks. A genetic counseling session is recommended to help interpret the results and discuss potential implications for you and your family.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
How to Book the Test
To take control of your genetic health, book the CHST14 Gene Ehlers-Danlos Syndrome Musculocontractural Type 1 NGS Genetic DNA Test today! Call or WhatsApp us at +2348110567037 to schedule your appointment.
